MRNA delays Q1 2025 results due to auditor change
Morabaha Marina Financing Co. (MRNA) stated that it will not be able to release its preliminary financial results for the three-month period ended March 31, 2025, within the statutory deadline.
The delay is due to the change from its former external auditor to PricewaterhouseCoopers Professional Services, which hindered the completion of the review process of the financials.
The company is working with the new auditor to complete the necessary procedures, and the financial statements are expected to be released by May 29, 2025.
MRNA stressed its commitment to complying with all applicable laws and regulations and will disclose the results immediately upon approval.
The preliminary statements will be published as soon as they are received and signed off by the authorized parties, it added.
The company will be subject to trading suspension procedures under listing rules and will issue monthly updates on the delay, along with prompt disclosure of any material developments.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
3 hours ago
- Arab News
Saudi Hajj minister, Mobily sign cooperation agreement to enhance digital experience
RIYADH: The Saudi Minister of Hajj and Umrah Tawfiq Al-Rabiah, and Mobily's CEO Nezar Banabeela have signed a cooperation agreement in Riyadh to enhance the digital experience for pilgrims and visitors to the Kingdom. Mobily is to assess digital infrastructure solutions to elevate service quality and enrich the overall digital experience of pilgrims and visitors, the Saudi Press Agency reported on Tuesday. The partnership reflects the ministry's commitment to engaging the private sector in delivering services that facilitate a smooth Hajj and Umrah experience.
Asharq Al-Awsat
7 hours ago
- Asharq Al-Awsat
Abu Dhabi's XRG Targets Gas, LNG Capacity of 20-25 Million Tons a Year by 2035
XRG, the international investment arm of Abu Dhabi National Oil Company (ADNOC), is aiming to have a gas and LNG business with a capacity of between 20 million and 25 million metric tons a year by 2035, the company said in a statement on Tuesday. XRG was set up last year as an investment company focused on lower-carbon energy, gas and chemicals, with assets of more than $80 billion. On Tuesday, its board, whose members include former BP CEO Bernard Looney and Blackstone's Jon Gray, approved the capacity target and a new five-year business plan. Board members also supported the assessment of potential gas acquisitions and LNG opportunities in North America, Reuters reported. ADNOC's current US investments already sit under XRG, and the oil giant's Chief Executive Sultan Al Jaber said in March that XRG would make a significant investment in US natural gas in coming months. XRG has also changed the name of its low carbon energies platform to Energy Solutions to reflect the full scope of the company's strategy, including energy demand linked to artificial intelligence and the digital economy, a company spokesperson said on Tuesday. The board "endorsed the company's ambition to create a top three global chemicals platform," XRG said. ADNOC had agreed in October to buy German chemicals maker Covestro for 14.7 billion euros ($16.73 billion) including debt. Jaber later said it would sit under XRG.
Arab News
7 hours ago
- Arab News
Makkah Health Cluster brings AI-powered healthcare platform ‘iSelfie' to region
The Makkah Health Cluster has signed a cooperation agreement with Canadian company AIZTech, which specializes in AI-powered medical diagnostics, to deploy the iSelfie platform across its facilities, including King Abdullah Medical City and several major hospitals in Makkah. The signing ceremony was attended by Jean-Philippe Linteau, ambassador of Canada to Saudi Arabia; Dr. Mubarak Al-Mulhem, director general of healthcare at the Ministry of Investment; and Dr. Hatim Al-Omari, CEO of the Makkah Health Cluster, which oversees more than 10 hospitals in the city. Also present were Dr. Adel Tash, CEO of King Abdullah Medical City, and Tarek Sultan, vice chairman of Agility. The agreement was signed by Al-Omari and Mohamed Sheta, CEO of AIZTech. This marks the first agreement of its kind in the Middle East, allowing patients to benefit from instant health assessments using AI through a short facial video, with no additional hardware required. The iSelfie platform analyzes the video to extract key health metrics including blood pressure, heart rate, blood oxygen saturation, and respiratory rate. The platform will be integrated into the patient-facing screens within hospital facilities and will be used with the assistance of medical staff. Al-Omari said: 'We are proud to be the first in the Kingdom and the region to adopt this advanced technology, which reflects our ongoing commitment to harnessing the latest digital solutions to enhance diagnostic efficiency and accelerate patient care. This step marks a qualitative leap toward a more advanced and innovative healthcare system, aligned with the goals of Saudi Vision 2030.' Tash added: 'In line with the spirit of digital transformation and the ambitious Saudi Vision 2030, we are pleased to launch this innovative AI-powered technology in Makkah. This launch is backed by a pivotal study conducted across the Kingdom, where the technology showed promising results when compared with 1,021 cases diagnosed using traditional medical devices. We are committed to expanding access to these advanced tools to benefit the wider community in the region.' Sheta said: 'We are honored to collaborate with one of the Kingdom's leading public healthcare institutions. This agreement is a clear indicator of the growing trust in AI-powered healthcare solutions and reinforces our belief that remote, non-invasive early diagnostics will be a core part of healthcare's future.' Ambassador Linteau said: 'Digital health innovation is gaining momentum in Canada, and Saudi Arabia is a market that is open to early adoption of innovation in the health sector.' He also expressed hope that the platform will achieve remarkable success in the early detection of health conditions in patients. The iSelfie platform has proven its effectiveness through clinical trials conducted in Saudi Arabia, the US, Canada, and Brazil, including a national study supported by the Saudi Food and Drug Authority. Results showed that the platform provides accurate readings comparable to traditional medical devices, with the added benefits of rapid assessment, accessibility, and cost efficiency. This collaboration aligns with the goals of Saudi Vision 2030, which places innovation and digital transformation at the heart of healthcare development by improving the quality of life, promoting preventive care, and expanding access to modern medical services.
